Marksans Pharma standalone net profit declines 53.52% in the September 2017 quarter
Sales rise 35.82% to Rs 75.41 crore
Net profit of Marksans Pharma declined 53.52% to Rs 1.32 crore in the quarter ended September 2017 as against Rs 2.84 crore during the previous quarter ended September 2016. Sales rose 35.82% to Rs 75.41 crore in the quarter ended September 2017 as against Rs 55.52 crore during the previous quarter ended September 2016. ParticularsQuarter EndedSep. 2017Sep. 2016% Var.Sales75.4155.52 36 OPM %8.43-0.65 -PBDT3.865.75 -33 PBT0.552.00 -73 NP1.322.84 -54Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 13 2017 | 3:59 PM IST